Publications by authors named "Heather Elizabeth Bell"
Diabetes Ther
November 2021
Article Synopsis
- OW semaglutide significantly improved glycemic control and body weight in adults with type 2 diabetes (T2D) in the real-world SURE UK study, confirming findings from prior SUSTAIN trials.
- The study measured the change in glycated hemoglobin (HbA) and found an average reduction of -16.3 mmol/mol and a mean body weight reduction of -5.8 kg over approximately 30 weeks.
- No new safety issues were reported, supporting the ongoing use of OW semaglutide in clinical practice for T2D management.
